rs56136489

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_StrongBP6BS2_Supporting

The NM_206933.4(USH2A):​c.14753C>T​(p.Thr4918Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00144 in 1,614,100 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T4918K) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0015 ( 3 hom. )

Consequence

USH2A
NM_206933.4 missense

Scores

6
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:6B:4

Conservation

PhyloP100: 1.42
Variant links:
Genes affected
USH2A (HGNC:12601): (usherin) This gene encodes a protein that contains laminin EGF motifs, a pentaxin domain, and many fibronectin type III motifs. The protein is found in the basement membrane, and may be important in development and homeostasis of the inner ear and retina. Mutations within this gene have been associated with Usher syndrome type IIa and retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.018091947).
BP6
Variant 1-215647560-G-A is Benign according to our data. Variant chr1-215647560-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 177746.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=3, Uncertain_significance=4}. Variant chr1-215647560-G-A is described in Lovd as [Likely_benign].
BS2
High Homozygotes in GnomAdExome4 at 3 AR geneVariant has number of homozygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
USH2ANM_206933.4 linkc.14753C>T p.Thr4918Met missense_variant Exon 67 of 72 ENST00000307340.8 NP_996816.3 O75445-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
USH2AENST00000307340.8 linkc.14753C>T p.Thr4918Met missense_variant Exon 67 of 72 1 NM_206933.4 ENSP00000305941.3 O75445-1
USH2AENST00000674083.1 linkc.14753C>T p.Thr4918Met missense_variant Exon 67 of 73 ENSP00000501296.1 O75445-3

Frequencies

GnomAD3 genomes
AF:
0.00134
AC:
204
AN:
152132
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000410
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000785
Gnomad ASJ
AF:
0.00288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00283
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00194
Gnomad OTH
AF:
0.00143
GnomAD3 exomes
AF:
0.00110
AC:
277
AN:
251328
Hom.:
1
AF XY:
0.00104
AC XY:
141
AN XY:
135840
show subpopulations
Gnomad AFR exome
AF:
0.000492
Gnomad AMR exome
AF:
0.000665
Gnomad ASJ exome
AF:
0.00198
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00180
Gnomad NFE exome
AF:
0.00156
Gnomad OTH exome
AF:
0.00130
GnomAD4 exome
AF:
0.00145
AC:
2122
AN:
1461850
Hom.:
3
Cov.:
31
AF XY:
0.00145
AC XY:
1054
AN XY:
727232
show subpopulations
Gnomad4 AFR exome
AF:
0.000209
Gnomad4 AMR exome
AF:
0.000693
Gnomad4 ASJ exome
AF:
0.00191
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.00170
Gnomad4 NFE exome
AF:
0.00170
Gnomad4 OTH exome
AF:
0.000927
GnomAD4 genome
AF:
0.00134
AC:
204
AN:
152250
Hom.:
0
Cov.:
32
AF XY:
0.00150
AC XY:
112
AN XY:
74432
show subpopulations
Gnomad4 AFR
AF:
0.000409
Gnomad4 AMR
AF:
0.000784
Gnomad4 ASJ
AF:
0.00288
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00283
Gnomad4 NFE
AF:
0.00194
Gnomad4 OTH
AF:
0.00142
Alfa
AF:
0.00154
Hom.:
0
Bravo
AF:
0.00105
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00174
AC:
15
ExAC
AF:
0.00120
AC:
146
EpiCase
AF:
0.00147
EpiControl
AF:
0.00148

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:6Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:5Benign:2
Sep 25, 2019
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The USH2A c.14753C>T; p.Thr4918Met variant (rs56136489) is reported in the literature in an individual affected with Usher syndrome type 2, although it was not demonstrated to be disease-causing and a second variant in this individual was not reported (McGee 2010). This variant is found in the general population with an overall allele frequency of 0.12% (331/282718 alleles, including one homozygote) in the Genome Aggregation Database. The threonine at codon 4918 is moderately conserved and computational analyses (SIFT, PolyPhen-2) predict that this variant is deleterious. However, due to limited information, the clinical significance of the p.Thr4918Met variant is uncertain at this time. References: McGee TL et al. Novel mutations in the long isoform of the USH2A gene in patients with Usher syndrome type II or non-syndromic retinitis pigmentosa. J Med Genet. 2010 Jul;47(7):499-506. -

Dec 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

USH2A: BP4, BS2 -

Oct 16, 2014
Eurofins Ntd Llc (ga)
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Uncertain significance
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jan 07, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Apr 02, 2021
GeneDx
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Identified in a patient with Usher syndrome type II in published literature, however no information about a second variant was provided (McGee et al., 2010); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 32707200, 24944099, 20507924) -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Uncertain significance
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Retinal dystrophy Uncertain:1
Jan 01, 2023
Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:1
Jul 30, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

p.Thr4918Met in exon 67 of USH2A: This variant is not expected to have clinical significance because it has been identified in 0.2% (119/66710) of European chro mosomes, including 1 homozygous individual, by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs56136489). Threonine (Thr) at pos ition 4918 is not conserved in mammals or evolutionarily distant species and 1 m ammal (Pacific walrus) carries a methionine (Met) at this position, suggesting t his change may be tolerated. Additional computational prediction tools do not pr ovide strong support for or against an impact to the protein. Although this vari ant has been reported in one individual with Usher syndrome type II, the authors classified it as a variant of uncertain significance and did not clarify whethe r a second USH2A variant was found in the individual (McGee 2010). -

Usher syndrome type 2A Benign:1
Jun 04, 2020
Natera, Inc.
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.43
CADD
Benign
16
DANN
Uncertain
1.0
DEOGEN2
Benign
0.36
T
Eigen
Benign
0.11
Eigen_PC
Benign
-0.052
FATHMM_MKL
Benign
0.51
D
LIST_S2
Benign
0.72
T
M_CAP
Uncertain
0.25
D
MetaRNN
Benign
0.018
T
MetaSVM
Benign
-0.62
T
MutationAssessor
Uncertain
2.8
M
PrimateAI
Benign
0.27
T
PROVEAN
Uncertain
-2.8
D
REVEL
Benign
0.24
Sift
Uncertain
0.0050
D
Sift4G
Uncertain
0.0030
D
Polyphen
1.0
D
Vest4
0.13
MVP
0.84
MPC
0.051
ClinPred
0.042
T
GERP RS
3.7
Varity_R
0.12
gMVP
0.47

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.10
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs56136489; hg19: chr1-215820902; API